Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study (original) (raw)

Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study

Anssi Auvinen, Teemu Murtola

American Journal of Epidemiology, 2008

View PDFchevron_right

Association between metabolic syndrome, diabetes mellitus and prostate cancer risk

Yaacov Lawrence, Adam Dicker

Prostate Cancer and Prostatic Diseases, 2013

View PDFchevron_right

Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men

ALPA PATEL

View PDFchevron_right

Metformin Use and Risk of Prostate Cancer: Results from the REDUCE Study

Gerald Andriole

Cancer prevention research (Philadelphia, Pa.), 2015

View PDFchevron_right

Diabetes and prostate cancer risk in the REDUCE trial

Daniel Moreira

Prostate Cancer and Prostatic Diseases, 2011

View PDFchevron_right

Diabetes Mellitus and Prostate Cancer Risk; A Nationwide Case-Control Study within PCBaSe Sweden

Soffia Gudbjörnsdottir

Cancer Epidemiology Biomarkers & Prevention, 2013

View PDFchevron_right

Impact of diabetes and metformin use on prostate cancer

Guila Delouya

Scandinavian Journal of Urology, 2020

View PDFchevron_right

Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada

Argelia Salas

BMC Public Health, 2015

View PDFchevron_right

Diabetes and Risk of Prostate Cancer

Chin-hsiao Tseng

Diabetes Care, 2011

View PDFchevron_right

Reduced risk of prostate cancer among patients with diabetes mellitus

Elisabete Weiderpass

International Journal of Cancer, 2002

View PDFchevron_right

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Gerald Andriole

Cancer Causes and …, 2008

View PDFchevron_right

Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study

Adedayo Onitilo

Clinical Medicine & Research, 2013

View PDFchevron_right

Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men

Liraz Olmer

Diabetologia, 2016

View PDFchevron_right

Diabetes mellitus and prostate cancer risk

Stacy Loeb

Expert Review of Endocrinology & Metabolism, 2010

View PDFchevron_right

Metabolic Syndrome Predicts Prostate Cancer in a Cohort of Middle-aged Norwegian Men Followed for 27 Years

Ingar Holme

American Journal of Epidemiology, 2006

View PDFchevron_right

Diabetes mellitus and prostate cancer risk among older men: population-based case-control study

Ann Coker

British journal of cancer, 2004

View PDFchevron_right

Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort

Karen Hersey

European Urology, 2014

View PDFchevron_right

Epidemiologic determinants of clinically relevant prostate cancer

Yuko Yamamura

International Journal of Cancer, 2000

View PDFchevron_right

Risk factors for prostate cancer: A case control study

Caspian Journal of Reproductive Medicine

Caspian Journal of Reproductive Medicine , 2016

View PDFchevron_right

Prostate cancer genetic propensity risk score may modify the association between this tumour and type 2 diabetes mellitus (MCC-Spain study)

Lluís Cecchini

Prostate Cancer and Prostatic Diseases, 2021

View PDFchevron_right

Risk factors for prostate cancer: A multifactorial case-control study

Saima Malik

View PDFchevron_right

Hypertension and Type 2 Diabetes Mellitus as Risk Factors for Prostate Cancer Patients in Southern Nigerians

John Raphael

Saudi journal of biomedical research, 2022

View PDFchevron_right

Statin Use as a Moderator of Metformin Effect on Risk for Prostate Cancer Among Type 2 Diabetic Patients

Carlos Lorenzo

Diabetes Care, 2012

View PDFchevron_right

The association between paternal prostate cancer and type 2 diabetes

Norbert Hermanns

Journal of Carcinogenesis, 2007

View PDFchevron_right

The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes

Christer Busch

Cancer Epidemiology, Biomarkers & Prevention, 2010

View PDFchevron_right

Risk of New-Onset Prostate Cancer for Metformin Versus Sulfonylurea Use in Type 2 Diabetes Mellitus: A Propensity Score–Matched Study

Jeremy Hui

Journal of the National Comprehensive Cancer Network

View PDFchevron_right